Geode Capital Management’s Baird Medical Investment Holdings BDMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.5K Sell
19,596
-5,846
-23% -$9.09K ﹤0.01% 4365
2026
Q1
$49.9K Hold
25,442
﹤0.01% 4313
2025
Q4
$34.6K Hold
25,442
﹤0.01% 4297
2025
Q3
$53.9K Hold
25,442
﹤0.01% 4275
2025
Q2
$93.2K Buy
25,442
+9,511
+60% +$49.9K ﹤0.01% 4075
2025
Q1
$83K Buy
15,931
+5,093
+47% +$30.5K ﹤0.01% 4079
2024
Q4
$82.4K Buy
+10,838
New +$29.9K ﹤0.01% 4145

Other funds holding BDMD

Geode Capital Management's BDMD Position: Q2 2026 in Review

Geode Capital Management reduced its Baird Medical Investment Holdings (BDMD) stake by 23% in Q2 2026, selling an estimated $9.09K and leaving 19,596 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4365.

Geode Capital Management first reported a position in BDMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $93.2K in Q2 2025. 6 funds tracked by Wall St. Rank hold BDMD as of Q2 2026.

  • Geode Capital Management held 19,596 shares of Baird Medical Investment Holdings worth $22.5K as of Q2 2026.
  • Geode Capital Management sold 5,846 Baird Medical Investment Holdings shares in Q2 2026, an estimated $9.09K.
  • Baird Medical Investment Holdings made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4365 holding.
  • Geode Capital Management first reported a position in Baird Medical Investment Holdings in Q4 2024 and has held it in 7 quarters since.
  • Geode Capital Management's Baird Medical Investment Holdings position peaked at $93.2K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.